| A Study of [13C]Pyruvate as an Imaging Agent for Magnetic Resonance Imaging in Healthy Volunteers (NCT05041166) | Memorial Sloan Kettering Cancer Center | 2021-09-01 |
| Flat Polypropylene Mesh in the Treatment of Uterine and Recurrent or Advanced Pelvic Organ Prolapse (NCT06225375) | Michigan Institution of Women's Health PC | 2021-09-01 |
| Short-Term Anti-plaque Effect of Cymenol Mouthwash Analysed Using Dentius Deep Plaque Software (NCT05521230) | University of Santiago de Compostela | 2021-09-01 |
| MPH966 for Prevention of Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation (NCT03986086) | Nelson Chao | 2021-09-01 |
| Analgesic Effect of Ketamine Vs Ketamine Magnesium Infusion and Their Effect on Postoperative Morphine Consumption (NCT05596669) | Egymedicalpedia | 2021-09-01 |
| A First-in-Human Study to Assess Single and Multiple Doses of NXC736 in Healthy Participants (NCT05079425) | NEXTGEN Bioscience | 2021-09-01 |
| Effect of Gamma-cyclodextrin on the Bioavailability of Ginsenosides (NCT04932265) | EuroPharma, Inc. | 2021-09-01 |
| The Study of Hemp Oil CBD for Evaluation of Efficacy and Safety in Treatment of Pain, Anxiety and Insomnia Management (NCT04729244) | Advanced Pain and Rehab Specialists | 2021-09-01 |
| Clinical Trial of Ublituximab and Umbralisib With CHOP (U2-CHOP) Followed by U2 Maintenance (U2-CHOP-U2) in Previously Untreated Mantle Cell Lymphoma (MCL) (NCT04692155) | University of Alabama at Birmingham | 2021-08-31 |
| A Study to Evaluate Safety and Efficacy of BEY1107 in Combination with Capecitabine in Patients with Metastatic Colorectal Cancer (NCT05093907) | BeyondBio Inc. | 2021-08-31 |
| A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK043 in Patients With Advanced Solid Tumor (NCT04964375) | Abbisko Therapeutics Co, Ltd | 2021-08-31 |
| Efficacy and Safety of Expanded UCMSCs On Patients With Moderate to Severe Psoriasis (NCT03745417) | Guangdong Provincial Hospital of Traditional Chinese Medicine | 2021-08-31 |
| A Study of TQB3820 in Patients With Hematological Malignancies (NCT05020639) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2021-08-31 |
| A Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Immunogenicity of HuL001 (NCT04540770) | HuniLife Biotechnology, Inc. | 2021-08-31 |
| Hypofractionated Radiation Therapy and Bintrafusp Alfa for the Treatment of Advanced Intrahepatic Cholangiocarcinoma (NCT04708067) | M.D. Anderson Cancer Center | 2021-08-31 |
| Tricaprilin Liquid Formulation PK Study (NCT05028114) | Cerecin | 2021-08-31 |
| The University of Michigan Wellness for Liver Health Study (NCT05010070) | University of Michigan | 2021-08-31 |
| SKLB1028, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia (AML) (NCT05445154) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2021-08-31 |
| A Food-drug Interaction Study of SY-004 in Healthy Subjects (NCT04907006) | Suzhou Yabao Pharmaceutical R&D Co., Ltd. | 2021-08-31 |
| Clinical Trial of IBC0966 in Patients With Advanced Malignant Tumors (NCT04980690) | SUNHO（China）BioPharmaceutical CO., Ltd. | 2021-08-31 |
| A Study of Nipocalimab With Co-administration of Etanercept or Hydroxychloroquine in Healthy Participants (NCT04973566) | Janssen Research & Development, LLC | 2021-08-31 |
| A Clinical Study of TQB3824 in Subjects With Advanced Cancer (NCT05028218) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2021-08-31 |
| Study to Estimate the Effects of Hepatic Impairment on the Pharmacokinetics (PK) of PF-07321332 (NCT05005312) | Pfizer | 2021-08-31 |
| A Study to Evaluate the Safety, Tolerability, and Exploratory Efficacy of IMS001 in Subjects With Multiple Sclerosis (NCT04956744) | ImStem Biotechnology | 2021-08-31 |
| Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL) (NCT04301076) | National Cancer Institute (NCI) | 2021-08-31 |
| Study of AMG 160 in Subjects With Non-Small Cell Lung Cancer (NCT04822298) | Amgen | 2021-08-31 |
| Testing the Combination of Two Immunotherapy Drugs (Magrolimab and Dinutuximab) in Patients With Relapsed or Refractory Neuroblastoma or Relapsed Osteosarcoma (NCT04751383) | National Cancer Institute (NCI) | 2021-08-31 |
| A Safety, Tolerability, Pharmacokinetics and Efficacy Study of GB261 in B-Cell NHL and CLL. (NCT04923048) | Genor Biopharma Co., Ltd. | 2021-08-31 |
| A Trial Evaluating the Safety and Immunogenicity of 3 COVID-19 SARS-CoV-2 RNA Vaccines in Healthy Adults (NCT05037097) | Arcturus Therapeutics, Inc. | 2021-08-30 |
| A Study to Learn How Safe the Study Drug BAY 2416964 (AhR Inhibitor) in Combination With the Treatment Pembrolizumab is, How This Combination Affects the Body, the Maximum Amount That Can be Given, How it Moves Into, Through and Out of the Body and Its Action Against Advanced Solid Cancers in Adults (NCT04999202) | Bayer | 2021-08-30 |
| Feasibility of [11C]Acetate-PET in LAM and TSC (NCT05467397) | Brigham and Women's Hospital | 2021-08-30 |
| The Safety and Efficacy of TWP-101 in Patients With Advanced Solid Tumor (NCT04871347) | Shandong TheraWisdom Biopharma Co., Ltd. | 2021-08-30 |
| Visual Surround Suppression and Perceptual Expectation Under Psilocybin (NCT04424225) | University of Minnesota | 2021-08-30 |
| MesoPher/Mitazalimab-combination Therapy in Metastatic Pancreatic Disease (REACtiVe-2 Trial) (NCT05650918) | Joachim Aerts, MD PhD | 2021-08-30 |
| A Phase 1 Study of Subcutaneous CDX-0159 in Healthy Subjects (NCT05031624) | Celldex Therapeutics | 2021-08-30 |
| A Research Study Looking Into Blood Levels of the Medicine NNC0480-0389 in Participants With Reduced Kidney Function Compared to Participants With Normal Kidney Function (NCT05015894) | Novo Nordisk A/S | 2021-08-30 |
| Mass Balance Recovery and Metabolite Identification of Carbon-14 BIA 28-6156 (NCT05220072) | Bial R&D Investments, S.A. | 2021-08-28 |
| Study of JS004 Combined With Toripalimab for Advanced Lung Cancer (NCT05000684) | Shanghai Junshi Bioscience Co., Ltd. | 2021-08-27 |
| Study of Fosciclopirox in Patients With Relapsed/Refractory Acute Myeloid Leukemia (NCT04956042) | CicloMed LLC | 2021-08-27 |
| A Study of Mass Balance, Pharmacokinetics, Metabolite Profile, and Metabolite Identification of BIIB122/DNL151 in Healthy Male Subjects (NCT05119790) | Biogen | 2021-08-27 |
| Pharmacokinetics Of Jaktinib In Subjects With Hepatic Impairment And Normal Hepatic Function (NCT04993404) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2021-08-27 |
| Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder (NCT05025605) | BioXcel Therapeutics Inc | 2021-08-27 |
| A Beta-only IL-2 ImmunoTherapY Study (NCT05086692) | Medicenna Therapeutics, Inc. | 2021-08-27 |
| Evaluate Sunosi® PK in Breast Milk and Plasma of Healthy Postpartum Women Following Single Dose Oral Administration (NCT05008341) | Axsome Therapeutics, Inc. | 2021-08-27 |
| KPT-9274 in Patients With Relapsed and Refractory Acute Myeloid Leukemia (NCT04914845) | University of Colorado, Denver | 2021-08-27 |
| Plasma P-tau2017 and Quantitative Amyloid PET Imaging (NCT05164536) | Invicro | 2021-08-27 |
| Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas (NCT04920032) | University of California, Irvine | 2021-08-26 |
| Phase Ib/II Clinical Study of Pexa-Vec (Vaccinia GM CSF / Thymidine Kinase-Deactivated Virus) Combined With Recombinant Whole Human Anti-PD-L1 Monoclonal Antibody (ZKAB001) in Metastatic Melanoma (NCT04849260) | Lee's Pharmaceutical Limited | 2021-08-26 |
| A Single and Multiple Ascending Dose Study of COR588 (NCT04920903) | Cortexyme Inc. | 2021-08-26 |
| Vancomycin Tissue Concentrations by Bier Block or Intravenous Administration (NCT04673877) | Mayo Clinic | 2021-08-26 |
| Relative Bioavailability of Intravenous GTX-104 Compared to Oral Nimodipine Capsules in Healthy Subjects (NCT05418348) | Grace Therapeutics Inc. | 2021-08-26 |
| Apatinib Mesylate Combined With IT Regimen for the Treatment of Recurrent or Refractory Pediatric Neuroblastoma: A Single-arm, Phase I/II，Multi-center, Clinical Study. (NCT05027386) | Sun Yat-sen University | 2021-08-26 |
| A Phase 1 Study of RO7623066 Alone and in Combination in Patients With Advanced Solid Tumors (NCT05240898) | Hoffmann-La Roche | 2021-08-26 |
| Dose-Finding, Safety, and Efficacy Study of XVR011 Added to Standard of Care in Patients Hospitalised for COVID-19 (NCT04884295) | ExeVir Bio BV | 2021-08-26 |
| A Study to Evaluate YH003 in Subjects With Advanced Solid Tumors (NCT05017623) | Eucure (Beijing) Biopharma Co., Ltd | 2021-08-26 |
| A Study of DT2216 in Relapsed/Refractory Malignancies (NCT04886622) | Dialectic Therapeutics, Inc | 2021-08-25 |
| Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer (NCT04491942) | National Cancer Institute (NCI) | 2021-08-25 |
| A Comparison of PRP Treatment to the IA vs. IA and EA Environments in Patients Diagnosed With Hip Osteoarthritis (NCT04241354) | Regenerative Orthopedics and Sports Medicine | 2021-08-25 |
| A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics of a Single Dose of Cenerimod (NCT04819464) | Viatris Innovation GmbH | 2021-08-25 |
| A Study Of Zy-19489 Administered Via Oral Route To Investigate The Safety, Tolerability And Pharmacokinetics In Healthy Adult Human Subjects (NCT05206201) | Zydus Lifesciences Limited | 2021-08-25 |
| NTX-301 Monotherapy in Advanced Solid Tumours and in Combination With Platinum-based Chemotherapy in Advanced Ovarian & Bladder Cancer and in Combination With Temozolomide in High-grade Glioma (NCT04851834) | Xennials Therapeutics Australia Pty Ltd | 2021-08-25 |
| Treatment of Ocular Demodex Infestation With Topical Ivermectin Cream 1% (NCT05213585) | Helm Vision Group | 2021-08-24 |
| Trial of XRD-0394, a Kinase Inhibitor, in Combination With Palliative Radiotherapy in Advanced Cancer Patients (NCT05002140) | XRad Therapeutics Inc | 2021-08-24 |
| A Phase 1，Open-label Study of BPI-421286 in Subjects With Advanced Solid Tumors (NCT05315180) | Betta Pharmaceuticals Co., Ltd. | 2021-08-24 |
| A Study of HSK29116 in Adults With Relapsed/Refractory B-cell Malignancies (NCT04861779) | Haisco Pharmaceutical Group Co., Ltd. | 2021-08-24 |
| Safety and Efficacy Evaluation of IM83 CAR-T Cells for Patients With Advanced Liver Tumors (NCT05123209) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2021-08-24 |
| Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Neurotrophic Keratitis Subjects (NCT04909450) | Claris Biotherapeutics, Inc. | 2021-08-24 |
| A Clinical Trial to Evaluate the Effect of Food on PK and PD of Vicagrel Capsules in Healthy Adult Subjects (NCT04919551) | Jiangsu vcare pharmaceutical technology co., LTD | 2021-08-24 |
| Single Dose and Multiple Dose Safety, Tolerability, PK，and Food Effect Study，and Interaction With Oseltamivir Study of HEC116094 in Healthy Adult Subjects (NCT04982913) | Sunshine Lake Pharma Co., Ltd. | 2021-08-24 |
| The Pharmacokinetics (PK), Safety, Tolerability of SR419 in Healthy Volunteers (NCT05012761) | Shanghai SIMR Biotechnology Co., Ltd. | 2021-08-24 |
| A Study of AK109 and AK104 in Advanced Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma (NCT04982276) | Akeso | 2021-08-23 |
| A Phase I Study of GT300 in Healthy Subjects (NCT04963855) | Generian Pharmaceuticals, Inc. | 2021-08-23 |
| A Study to Assess the Safety, Tolerability and Pharmacokinetics of BSG005. (NCT04921254) | Biosergen AS | 2021-08-23 |
| Acalabrutinib in CNSL (NCT04906902) | Dana-Farber Cancer Institute | 2021-08-23 |
| Pre-operative Immunotherapy in Stage II-III Urothelial Cancer (NCT04871594) | The Netherlands Cancer Institute | 2021-08-23 |
| A Study to Evaluate a New Tablet Formulation of Lu AG06466 in Healthy Participants (NCT05028673) | H. Lundbeck A/S | 2021-08-23 |
| A Bioequivalence Study of a New Paracetamol Oral Suspension 24mg/ml Compared to the Marketed Paracetamol Oral Suspension (Panadol Baby and Infant 24mg/ml) in Healthy Adult Subjects (NCT05022810) | HALEON | 2021-08-23 |
| ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors (NCT04732065) | Sabine Mueller, MD, PhD | 2021-08-23 |
| SAD Study of IA-14069 (NCT05317741) | ILAb Co., Ltd. | 2021-08-23 |
| Investigator-initiated Clinical Trial of MIKE-1 (NCT05064618) | Nagoya University | 2021-08-23 |
| Pharmacokinetics, Immunogenicity, Safety and Tolerability of MEDI3506 in Health Chinese Participants (NCT05070312) | AstraZeneca | 2021-08-23 |
| The University of Michigan OWL (Online Wellness and Lifestyle) Study (NCT05010083) | University of Michigan | 2021-08-23 |
| A Phase 1, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics of HRS4800 in Healthy Subjects (NCT04991909) | Jiangsu HengRui Medicine Co., Ltd. | 2021-08-23 |
| A Study of FWD1509 in Adults With Non-Small Cell Lung Cancer (NCT05068024) | Forward Pharmaceuticals Co., Ltd. | 2021-08-23 |
| A Bioequivalence Study to Compare the Pharmacokinetics of Two Formulations of Siklos® in Healthy Volunteers (NCT05025072) | Theravia | 2021-08-22 |
| Effect of Vitamin D Oral Supplementation in Poly Csytic Ovarian Women Resistant to Clomiphene Citrate (NCT04916925) | rana alaaeldin aly ibrahim nasr | 2021-08-21 |
| Study to Assess the Pharmacokinetics, Safety and Tolerability of Aztreonam-Avibactam in Healthy Chinese Participants. (NCT04973826) | Pfizer | 2021-08-20 |
| NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers (NCT05020678) | Nkarta, Inc. | 2021-08-20 |
| Effect of Coadministration of Sotorasib on the Pharmacokinetics of Rosuvastatin in Healthy Participants (NCT05045638) | Amgen | 2021-08-20 |
| Study of Epigallocatechin-3-gallate (EGCG) for Supportive and Symptomatic Management in Patients With Esophageal Cancer (NCT05039983) | Shandong Cancer Hospital and Institute | 2021-08-20 |
| Capecitabine-based Chemoradiotherapy in Combination With the IL-1 Receptor Antagonist Anakinra for Rectal Cancer Patients (NCT04942626) | Goethe University | 2021-08-20 |
| Safety and Efficacy Study of Investigational Agents as Monotherapy or in Combination With Pembrolizumab (MK-3475) for the Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Need of Second-Line Therapy (MK-3475-B98/KEYNOTE-B98) (NCT04938817) | Merck Sharp & Dohme LLC | 2021-08-19 |
| Nivolumab and Pembrolizumab Dose Optimisation in Solid Tumours With CURATE.AI Platform and Sequential ctDNA Measurements (NCT05175235) | National University Hospital, Singapore | 2021-08-19 |
| Testing the Addition of the Anti-cancer Drug, Tazemetostat, to the Usual Treatment (Dabrafenib and Trametinib) for Metastatic Melanoma That Has Progressed on the Usual Treatment (NCT04557956) | National Cancer Institute (NCI) | 2021-08-19 |
| Influenza Challenge Study to Determine the Optimal Infection Dose and Safety of a Recombinant H3N2 (A/Texas/71/2017 (H3N2, Clade 3C3a) Influenza Strain (NCT04978454) | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-08-19 |
| Study of SQZ-AAC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors (NCT04892043) | SQZ Biotechnologies | 2021-08-19 |
| Relative Bioavailability and Food Effect Study of Losmapimod 15 mg Tablets (NCT05002231) | Fulcrum Therapeutics | 2021-08-19 |
| To Assess the Safety and Tolerability of INCB000928 in Participants With Myelodysplastic Syndromes or Multiple Myeloma (NCT04582539) | Incyte Corporation | 2021-08-19 |
| A Research Study Looking at How the Medicine NNC0385-0434 Works in the Body of Healthy Japanese Men (NCT05003440) | Novo Nordisk A/S | 2021-08-19 |
| GFRα4 CAR T Cells in MTC Patients (NCT04877613) | University of Pennsylvania | 2021-08-19 |